结合转录组景观在质母细胞瘤:发病率和治疗影响
Sonikpreet Aulakh1, Joanne Xiu2, Shawn Kothari3
1Department of Medical Oncology, West Virginia University, Morgantown.
Neuro-oncology advances
|January 27, 2026
概括
大约9%的质母细胞瘤 (GBM) 病例具有可向的基因融合,主要涉及FGFR3,MET和EGFR. 这些发现表明,在特定的GBM分子子组中,有针对性治疗的潜力.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 质母细胞瘤 (GBM) 是一个重大的挑战,因为缺乏有效的治疗方法来治疗复发性疾病.
- 基因融合在GBM的发病率和治疗相关性尚未得到充分确立,与其他成功的融合向治疗的癌症不同.
研究的目的:
- 为了确定一大群质母细胞瘤中基因融合的频率.
- 根据融合状态,在GBM内识别分子关联和潜在的治疗点.
主要方法:
- 来自4800个IDH野生型GBM样本的下一代DNA测序和全转录组测序数据的分析.
- 使用费舍尔精确和奇平方测试进行统计分析,并对本杰明尼-霍赫伯格的显著性进行调整 (q < 0.05).
主要成果:
- 在8.9%的GBM样本中发现了致病基因融合,其中FGFR3,MET和EGFR是最常见的.
- 与聚变阳性瘤相比,聚变阳性GBM显示出明显的放大和突变概况.
- 融合阳性患者 (16.6个月) 与融合阴性患者 (15.5个月) 的中位生存时间略有改善,尽管氨酸激酶抑制剂 (TKI) 治疗没有显著的生存益处.
结论:
- 大约9%的GBM具有可向的融合基因,其中FGFR3,MET,EGFR,NTRK2和PDGFRA是关键基因.
- 这些发现支持开发多臂临床试验,研究分子定义的GBM亚组的向疗法.
相关概念视频
Prevalence and Incidence
1.8K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.8K
Nuclear Fusion
33.8K
The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
33.8K
Types of Reports II: Incident or Occurrence Report
1.2K
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
1.2K
Therapeutic Index
6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
Tagging and Fusion Proteins
8.4K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
8.4K
SNAREs and Membrane Fusion
12.7K
Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
12.7K


